September 5, 2018 — Biotronik announced it is now the exclusive U.S. distributor for the MoMe Kardia external cardiac diagnostic monitor from digital health company InfoBionic. The device benefits patients suspected of experiencing cardiac arrhythmias.
According to InfoBionic, MoMe Kardia is the first and only deep learning software as a service (SaaS) remote cardiac monitoring platform that replicates in-hospital monitoring with full disclosure cardiac data delivered direct to physicians for 24/7 on-demand review via a HIPAA-compliant portal. By giving physicians control of when, where and how they review monitoring reports – as well as access to beat-to-beat data to verify events – MoMe Kardia can significantly reduce time to diagnosis and intervention. The model also positively impacts practice economics by giving physicians full ownership of monitoring services.
Patients experiencing cardiac arrhythmias face an increased risk of personal injury from falls, motor vehicle accidents, stroke and possibly heart failure. MoMe is designed to increase early detection and diagnosis of cardiac arrhythmias by providing physicians with the ability to access near real-time electrocardiographic data. Monitoring can also uncover patients at higher risk of sudden cardiac death. Hospitalizations and life-threatening cardiac events decrease with early diagnosis and treatment.
With automated cloud-based analytics, patient data is immediately available to physicians without the need for costly third-party services. MoMe creates access to information that enables intervention to prevent negative outcomes. Medication compliance can be identified and managed, symptoms can be correlated with rhythms, and triggers of cardiac events can be found by analyzing the onset and resolution data of an event.
Speaking to the benefits his practice has seen since using the MoMe Kardia system, Matthew B. Hillis, M.D., FACC, FHRS of Marple Medical Associates in Broomall, Pa., explained, “The workflow has been more efficient for us from both the staff and physician perspective. Customizable alerts, utilization tracking/inventory management, improved patient comfort and compliance have been beneficial. The quality of ECG [electrocardiogram] tracings is high, and we have found the business model to be useful as well.”
"MoMe is unique in providing near real-time full disclosure electrocardiographic monitoring," said Colin Movsowitz, M.D., electrophysiologist, Philadelphia. "It replicates a hospital telemetry monitoring center. MoMe allows clinical decisions to be made on data rather than assumptions. It sets a new standard in providing physicians easy access to ambulatory electrocardiographic data."
Patients can easily be trained on how to use the one-button monitor. Once the patient is home, physicians can remotely switch the monitor between Holter, Event and Mobile Cardiac Telemetry — lessening the need for office visits and saving time and money for the patient. From enrollment to diagnosis, physicians have total control of the monitor.
For more information: www.infobionic.com, www.biotronik.com
August 15, 2024 
